RxDoctor Payments Data

Yuriy Dobry, MD

Psychiatry · Campbell, CANPI 1245558881

Payments from drug & device makers

$6,688in general payments, 2019–2025

Across 395 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Bausch Health US, LLC$823
  • Lundbeck LLC$696
  • Alkermes, Inc.$606
  • Axsome Therapeutics, Inc.$449
  • Otsuka America Pharmaceutical, Inc.$442
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$6,688100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,688 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$228,525
Medicare patients
101
Services billed
1,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl22$43,084
RexultiBrexpiprazole14$19,547
VraylarCariprazine Hcl12$16,636
Aripiprazole15$2,522
Ramelteon12$1,769
Bupropion XlBupropion Hcl29$798
Lamotrigine20$429
Alprazolam ErAlprazolam13$424
Gabapentin14$395
Trazodone Hcl14$279
Fluoxetine Hcl20$196
Quetiapine Fumarate13$152
Escitalopram Oxalate12$123
Paroxetine Hcl22$95
Mirtazapine21$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$126$43,08422 claims
Otsuka America Pharmaceutical, Inc.Rexulti$442$19,54714 claims
AbbVieVraylar$1,790$16,63612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Campbell

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →